Key result
FDG PET/CT can detect, stage, and monitor a wide variety of malignant pleural and pericardial diseases, although imaging findings are often nonspecific.
This pictorial review highlights the utility of 18F-FDG PET/CT in detecting, staging, and monitoring a wide variety of malignant pleural and pericardial diseases.
Answers are grounded in this paper and cite their sources.
May aid evaluation of malignant pleural/pericardial diseases; leaves open need for prospective validation given nonspecific findings.
OBJECTIVE: The purpose of this article is to illustrate a wide spectrum of malignant primary and secondary pleural and pericardial diseases imaged with (18)F-FDG PET/CT. CONCLUSION: A wide variety of malignant pleural and pericardial diseases can be detected, staged, and monitored by FDG PET/CT. Although the PET/CT findings are often nonspecific, the aim of this atlas is to show that the spectrum of pleural and pericardial disease that can be evaluated with PET/CT is much broader than current literature would suggest. PET/CT readers and oncologists should be aware of the wide variety of malignancies that can affect the pleura and pericardium and some of the patterns of FDG uptake that can be observed in these cases.
No takes yet. Share an insight, caveat, or question.
Makis et al. (2012) conducted a review in Malignant pleural and pericardial disease. (18)F-FDG PET/CT was evaluated. FDG PET/CT can detect, stage, and monitor a wide variety of malignant pleural and pericardial diseases, although imaging findings are often nonspecific.
Synapse has enriched 10 related papers. Consider them for comparative context: